Browsing Artículos by Author "Echebarria Barona, Aizpea Beatriz"
Now showing items 1-3 of 3
-
Clinical management of the acute complications of sickle cell anemia: 11 years of experience in a tertiary hospital
Reparaz Goñi, Patricia; Serrano Pejenaute, Idoya; Adán Pedroso, Rosa; Astigarraga Aguirre, María Iciar; De Pedro Olabarri, Jimena; Echebarria Barona, Aizpea Beatriz; García Ariza, Miguel; López Almaraz, Ricardo; Del Orbe Barreto, Rafael Andrés; Vara Pampliega, Miriam; González Urdiales, Paula (Elsevier, 2022-07)Sickle cell disease is an emerging anemia in Europe leading to high morbidity with severe acute complications requiring hospital admission and chronic consequences. The management of these patients is complex and needs ... -
Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing
Alba Pavón, Piedad; Alaña, Lide; Gutiérrez Jimeno, Miriam; García Obregón, Susana; Imízcoz, Teresa; Panizo, Elena; González Urdiales, Paula; Echebarria Barona, Aizpea Beatriz; López Almaraz, Ricardo; Zaldumbide Dueñas, Laura; Astigarraga Aguirre, María Iciar; Patiño García, Ana; Villate, Olatz (Nature, 2023-02)Genetic predisposition is an important risk factor for cancer in children and adolescents but detailed associations of individual genetic mutations to childhood cancer are still under intense investigation. Among pediatric ... -
Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia
Martín Guerrero, Idoia; Gutiérrez Camino, Ángela ; Echebarria Barona, Aizpea Beatriz; Astigarraga Aguirre, María Iciar; García de Andoin Barandiaran, Nagore; Navajas Gutiérrez, Aurora; García-Orad Carles, África (Springer, 2019-02-06)Vincristine is an important drug of acute lymphoblastic leukemia (ALL) treatment protocols that can cause neurotoxicity. Patients treated with LAL/SHOP protocols often suffer from vincristine-related neurotoxicity in early ...